Dxn Pharmaceutical Sdn Bhd
FDA inspection history on file, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483.
Cited most
Across all Dxn Pharmaceutical Sdn Bhd observations on file
- 21 CFR 111.210What must the master manufacturing record include?1
The complete Dxn Pharmaceutical Sdn Bhd file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-03-06 | 483 Form 483 | — | 1 | $99 |
Investigators on these documents
FEI number 3006649152 · most recent document Mar 6, 2026
About Dxn Pharmaceutical Sdn Bhd
How many FDA Form 483s has Dxn Pharmaceutical Sdn Bhd received?
FDA Intel has 1 Form 483 on file for Dxn Pharmaceutical Sdn Bhd; the most recent is dated Mar 6, 2026.
When was Dxn Pharmaceutical Sdn Bhd last inspected by FDA?
The most recent FDA inspection document on file for Dxn Pharmaceutical Sdn Bhd is a Form 483 dated Mar 6, 2026.
What did FDA cite at Dxn Pharmaceutical Sdn Bhd?
The regulations cited most in the observations on file for Dxn Pharmaceutical Sdn Bhd are 21 CFR 111.210 (What must the master manufacturing record include?), 1 time.